Filed before 2025Filed 5 August 2024
Vedanta Biosciences, Inc. has sold $118M so far
Vedanta Biosciences, Inc., a biotech company based in Cambridge, MA, has sold $118M so far in its debt round, according to a filing dated 5 August 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 5 August 2024
- First filed
- 2 May 2023
- Round
- Debt round (amended filing)
- Amount sold
- $118M
- Offering size
- $118M
- Investors so far
- 25
- Based in
- Cambridge, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 96% of the 1,434 tracked raises with an amount filed in 2024, and than 88% of the 138 in biotech.
Vedanta Biosciences, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 5 Aug 2024 | Amended filing | $118M | This raise |
| 2 May 2023 | New filing | $106M | This raise |
More with Tullis on the board
- Novocuff, Inc.$6.76M
- Cxl Ophthalmics, Inc.$26.4M
- Ophirex, Inc.$16.5M
- Revelation Biosciences, Inc$5.14M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.